FDA Import Refusal 1FX-2681698-4/10002/6 — CARE FORMULATION LABS PRIVATE LI
The FDA refused shipment 1FX-2681698-4/10002/6 from CARE FORMULATION LABS PRIVATE LI (India) on Oct 8, 2026. The refused product falls under Drugs and Biologics — ANTI-INFLAMMATORY N.E.C.. Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Oct 8, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GDA99 ANTI-INFLAMMATORY N.E.C.
- Charges
- 75